Cancer Research Cell Death Mechanisms and Cancer Therapy  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, P.
Right arrow Articles by Cheng, S.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, P.
Right arrow Articles by Cheng, S.-Y.
[Cancer Research 61, 8569-8577, December 1, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Vascular Endothelial Growth Factor Isoforms Display Distinct Activities in Promoting Tumor Angiogenesis at Different Anatomic Sites1

Ping Guo, Li Xu2, Shi Pan2, Rolf A. Brekken, Shu-Ting Yang, G. Brian Whitaker, Motoo Nagane, Philip E. Thorpe, Jan S. Rosenbaum, H.-J. Su Huang, Webster K. Cavenee and Shi-Yuan Cheng3

University of Pittsburgh Cancer Institute and Department of Pathology, Pittsburgh, Pennsylvania 15213 [P. G., L. X., S. P., S-T. Y., S-Y. C.]; Department of Vascular Biology, The Hope Heart Institute, Seattle, Washington 98104-2016 [R. A. B.]; and Cardiovascular Research, Procter and Gamble Pharmaceuticals, Mason, Ohio 45040 [G. B. W., J. S. R.]; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, 75235-9111 [P. E. T.]; and Ludwig Institute for Cancer Research, San Diego Branch, Department of Medicine, and Center for Molecular Genetics, University of California, San Diego, La Jolla, California, 92093-0660 [M. N., H.-J. S. H., W. K. C.]

The gene for the major angiogenic factor, vascular endothelial growth factor (VEGF), encodes several spliced isoforms. We reported previously that overexpression of two VEGF isoforms, VEGF121 and VEGF165, by human glioma U87 MG cells induced tumor-associated intracerebral hemorrhage, whereas expression of a third form, VEGF189, did not cause vessel rupture. Here, we test whether these VEGF isoforms have distinct activities for enhancing vascularization and growth of gliomas in mice. U87 MG cells that overexpressed VEGF165 or VEGF189 grew more rapidly than the parental cells in both s.c. and intracranial (i.c.) locations. However, cells that overexpressed VEGF121 only showed enhancement of i.c. tumor growth but had a minimal effect on s.c. glioma progression. At both anatomical sties, VEGF165 and VEGF189 strongly augmented neovascularization, whereas VEGF121 only increased vessel density in brain tumors. In each type of glioma, expression of VEGF receptors -1 and -2 largely phenocopied the tumor vasculature, because increased VEGF/VEGF receptor-activated microvessel densities were strongly correlated with the angiogenicity and tumorigenicity elicited by the VEGF isoforms at both anatomical sites. One notable difference between the sites was the expression of vitronectin, a prototypic ligand of {alpha}vß3 and {alpha}vß5 integrins, detected in i.c. but not in s.c., gliomas. Endothelial cell migration stimulated by VEGF121 was potentiated by vitronectin to a greater extent than that stimulated by VEGF165. This data demonstrates that VEGF isoforms have distinct activities at different anatomical sites and suggest that the microenvironment of different tissues affects the function of VEGF isoforms.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Lorger, J. S. Krueger, M. O'Neal, K. Staflin, and B. Felding-Habermann
Activation of tumor cell integrin {alpha}v{beta}3 controls angiogenesis and metastatic growth in the brain
PNAS, June 30, 2009; 106(26): 10666 - 10671.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. M. Tozer, S. Akerman, N. A. Cross, P. R. Barber, M. A. Bjorndahl, O. Greco, S. Harris, S. A. Hill, D. J. Honess, C. R. Ireson, et al.
Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform-Producing Tumors
Cancer Res., April 1, 2008; 68(7): 2301 - 2311.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. Belotti, C. Calcagno, A. Garofalo, D. Caronia, E. Riccardi, R. Giavazzi, and G. Taraboletti
Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion
Mol. Cancer Res., April 1, 2008; 6(4): 525 - 534.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M.-A. Herve, H. Buteau-Lozano, R. Vassy, I. Bieche, G. Velasco, M. Pla, G. Perret, S. Mourah, and M. Perrot-Applanat
Overexpression of Vascular Endothelial Growth Factor 189 in Breast Cancer Cells Leads to Delayed Tumor Uptake with Dilated Intratumoral Vessels
Am. J. Pathol., January 1, 2008; 172(1): 167 - 178.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Sakao, L. Taraseviciene-Stewart, C. D. Cool, Y. Tada, Y. Kasahara, K. Kurosu, N. Tanabe, Y. Takiguchi, K. Tatsumi, T. Kuriyama, et al.
VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells
FASEB J, November 1, 2007; 21(13): 3640 - 3652.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. L. Springer, A. Banfi, J. Ye, G. von Degenfeld, P. E. Kraft, S. A. Saini, N. K. Kapasi, and H. M. Blau
Localization of vascular response to VEGF is not dependent on heparin binding
FASEB J, July 1, 2007; 21(9): 2074 - 2085.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kanamori, T. Kawaguchi, M. S. Berger, and R. O. Pieper
Intracranial Microenvironment Reveals Independent Opposing Functions of Host {alpha}Vbeta3 Expression on Glioma Growth and Angiogenesis
J. Biol. Chem., December 1, 2006; 281(48): 37256 - 37264.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Su, Q. Zheng, M. M. Vaughan, Y. Bu, and I. H. Gelman
SSeCKS Metastasis-Suppressing Activity in MatLyLu Prostate Cancer Cells Correlates with Vascular Endothelial Growth Factor Inhibition
Cancer Res., June 1, 2006; 66(11): 5599 - 5607.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Price, C. Dent, B. Duran-Jimenez, Y. Liang, L. Zhang, E. J. Rebar, C. C. Case, P. D. Gregory, T. J. Martin, S. K. Spratt, et al.
Gene Transfer of an Engineered Transcription Factor Promoting Expression of VEGF-A Protects Against Experimental Diabetic Neuropathy
Diabetes, June 1, 2006; 55(6): 1847 - 1854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Guo, Y. Imanishi, F. C. Cackowski, M. J. Jarzynka, H.-Q. Tao, R. Nishikawa, T. Hirose, B. Hu, and S.-Y. Cheng
Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 {gamma} 2 Correlates with the Invasiveness of Human Glioma
Am. J. Pathol., March 1, 2005; 166(3): 877 - 890.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Kirsch, P. Weigel, T. Pinzer, R. S. Carroll, P. McL. Black, H.-K. Schackert, and G. Schackert
Therapy of Hematogenous Melanoma Brain Metastases with Endostatin
Clin. Cancer Res., February 1, 2005; 11(3): 1259 - 1267.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. S. Wang, J. Teruya-Feldstein, Y. Wu, Z. Zhu, D. J. Hicklin, and M. A. S. Moore
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo
Blood, November 1, 2004; 104(9): 2893 - 2902.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
K. M. Schmainda, S. D. Rand, A. M. Joseph, R. Lund, B. D. Ward, A. P. Pathak, J. L. Ulmer, M. A. Baddrudoja, and H. G. J. Krouwer
Characterization of a First-Pass Gradient-Echo Spin-Echo Method to Predict Brain Tumor Grade and Angiogenesis
AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1524 - 1532.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bornes, M. Boulard, C. Hieblot, C. Zanibellato, J. S. Iacovoni, H. Prats, and C. Touriol
Control of the Vascular Endothelial Growth Factor Internal Ribosome Entry Site (IRES) Activity and Translation Initiation by Alternatively Spliced Coding Sequences
J. Biol. Chem., April 30, 2004; 279(18): 18717 - 18726.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kanamori, S. R. V. Berg, G. Bergers, M. S. Berger, and R. O. Pieper
Integrin {beta}3 Overexpression Suppresses Tumor Growth in a Human Model of Gliomagenesis: Implications for the Role of {beta}3 Overexpression in Glioblastoma Multiforme
Cancer Res., April 15, 2004; 64(8): 2751 - 2758.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. K. Noren, M. Lu, A. L. Freeman, M. Koolpe, and E. B. Pasquale
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth
PNAS, April 13, 2004; 101(15): 5583 - 5588.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Kusters, R. M. W. de Waal, P. Wesseling, K. Verrijp, C. Maass, A. Heerschap, J. O. Barentsz, F. Sweep, D. J. Ruiter, and W. P. J. Leenders
Differential Effects of Vascular Endothelial Growth Factor A Isoforms in a Mouse Brain Metastasis Model of Human Melanoma
Cancer Res., September 1, 2003; 63(17): 5408 - 5413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Guo, Q. Fang, H.-Q. Tao, C. A. Schafer, B. M. Fenton, I. Ding, B. Hu, and S.-Y. Cheng
Overexpression of Vascular Endothelial Growth Factor by MCF-7 Breast Cancer Cells Promotes Estrogen-independent Tumor Growth in Vivo
Cancer Res., August 1, 2003; 63(15): 4684 - 4691.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Hu, P. Guo, Q. Fang, H.-Q. Tao, D. Wang, M. Nagane, H.-J. Su Huang, Y. Gunji, R. Nishikawa, K. Alitalo, et al.
Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2
PNAS, July 22, 2003; 100(15): 8904 - 8909.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Sonoda, M. Kanamori, D. F. Deen, S.-Y. Cheng, M. S. Berger, and R. O. Pieper
Overexpression of Vascular Endothelial Growth Factor Isoforms Drives Oxygenation and Growth but not Progression to Glioblastoma Multiforme in a Human Model of Gliomagenesis
Cancer Res., April 15, 2003; 63(8): 1962 - 1968.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Guo, B. Hu, W. Gu, L. Xu, D. Wang, H.-J. S. Huang, W. K. Cavenee, and S.-Y. Cheng
Platelet-Derived Growth Factor-B Enhances Glioma Angiogenesis by Stimulating Vascular Endothelial Growth Factor Expression in Tumor Endothelia and by Promoting Pericyte Recruitment
Am. J. Pathol., April 1, 2003; 162(4): 1083 - 1093.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.